2nd Quarter - Report

BIOCOM for BIOCOM

Firm
Client
Income
—
Expenses
$57,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 1249: Patent Reform BIOCOM supports establishing the principle of fee retention with respect to fees collected by the USPTO. BIOCOM also supports the proposed modifications to post-grant opposition; BIOCOM supports the proposed supplemental examination procedure included in the Managers Amendment

LobbyistCovered position, as disclosed
MADELEINE BAUDOIN —
JOE PANETTA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1249 (112th)

Taxation/Internal Revenue Code TAX

Medical Device Excise Tax Repeal Bills BIOCOM supports repealing the 2.3 ($20 billion) tax on medical device companies. HR 734: To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes Summery: Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. Rescinds $39 billion of appropriated but unobligated discretionary funds. Exempts funds of the DOD and VA. HR 436: Protect Medical Innovation Act of 2011 Summery: Amends the Internal Reveue Code to repeal the excise tax on medical devices. Therapeutic Discovery Project ("TDP") Program BIOCOM supports an extension of the TDP, which expired at the end of 2010.

LobbyistCovered position, as disclosed
MADELEINE BAUDOIN —
JOE PANETTA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 734 (112th), H.R. 436 (112th)

Small Business SMB

The Small Business Innovation Research Program ("SBIR") BIOCOM supported BIR Reauthorization before the program was set to expire on May 31

LobbyistCovered position, as disclosed
MADELEINE BAUDOIN —
JOE PANETTA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Repeal of Independent Payment Advisory Board ("IPAB") BIOCOM supports the repeal of the IPAB which was created with the passage of The Patient Protection and Affordable Care Act ("PPACA").

LobbyistCovered position, as disclosed
MADELEINE BAUDOIN —
JOE PANETTA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.